Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 560

1.

HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES IN EUROPE: PROCESSES, PRACTICES, AND METHODS.

Fuchs S, Olberg B, Panteli D, Busse R.

Int J Technol Assess Health Care. 2016 Sep 27:1-10. [Epub ahead of print]

PMID:
27670589
2.

Descriptive, cross-country analysis of the nurse practitioner workforce in six countries: size, growth, physician substitution potential.

Maier CB, Barnes H, Aiken LH, Busse R.

BMJ Open. 2016 Sep 6;6(9):e011901. doi: 10.1136/bmjopen-2016-011901.

3.

Evaluating the Impact of an Accountable Care Organization on Population Health: the Quasi-Experimental Design of the German Gesundes Kinzigtal.

Pimperl A, Schulte T, Mühlbacher A, Rosenmöller M, Busse R, Groene O, Rodriguez HP, Hildebrandt H.

Popul Health Manag. 2016 Aug 26. [Epub ahead of print]

PMID:
27565005
4.

Canada: Focus on a country's health system with provincial diversity.

Sutherland JM, Busse R.

Health Policy. 2016 Jul;120(7):729-31. doi: 10.1016/j.healthpol.2016.06.010. No abstract available.

PMID:
27381071
5.

South Korea: An interesting case to study.

Kwon S, Busse R.

Health Policy. 2016 Jun;120(6):577-9. doi: 10.1016/j.healthpol.2016.06.002. No abstract available.

PMID:
27321546
6.

The iMpact on practice, oUtcomes and costs of New roles for health pROfeSsionals: a study protocol for MUNROS.

Bond C, Bruhn H, de Bont A, van Exel J, Busse R, Sutton M, Elliott R; MUNROS team.

BMJ Open. 2016 Apr 26;6(4):e010511. doi: 10.1136/bmjopen-2015-010511.

7.

How do Chronically Ill Patients Rate Medical Care by their GPs and Specialists? Results of a Germany-wide Survey.

Röttger J, Busse R.

Gesundheitswesen. 2016 Sep;78(S 01):e89-e96. Epub 2016 Feb 16.

8.

Health-care improvements in a financially constrained environment.

Ekman I, Busse R, van Ginneken E, Van Hoof C, van Ittersum L, Klink A, Kremer JA, Miraldo M, Olauson A, De Raedt W, Rosen-Zvi M, Strammiello V, Törnell J, Swedberg K.

Lancet. 2016 Feb 13;387(10019):646-7. doi: 10.1016/S0140-6736(16)00285-3. No abstract available.

PMID:
26876711
9.

The policy contribution of the German Health Economic Centres.

Sundmacher L, Busse R.

Health Policy. 2016 Feb;120(2):139-40. doi: 10.1016/j.healthpol.2016.01.019. Epub 2016 Jan 28. No abstract available.

PMID:
26851990
10.

Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.

Panteli D, Nolting A, Eckhardt H, Kulig M, Busse R.

Health Res Policy Syst. 2016 Jan 26;14:6. doi: 10.1186/s12961-016-0080-9.

11.

Forgone care among chronically ill patients in Germany-Results from a cross-sectional survey with 15,565 individuals.

Röttger J, Blümel M, Köppen J, Busse R.

Health Policy. 2016 Feb;120(2):170-8. doi: 10.1016/j.healthpol.2016.01.004. Epub 2016 Jan 11.

PMID:
26806678
12.

TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT.

Henschke C, Panteli D, Perleth M, Busse R.

Int J Technol Assess Health Care. 2015 Jan;31(5):324-30. doi: 10.1017/S0266462315000562. Epub 2015 Dec 29.

PMID:
26711471
13.

CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES.

Panteli D, Kreis J, Busse R.

Int J Technol Assess Health Care. 2015 Jan;31(5):314-23. doi: 10.1017/S0266462315000549. Epub 2015 Dec 29.

PMID:
26711222
14.

Analyzing Protein-Phosphoinositide Interactions with Liposome Flotation Assays.

Busse RA, Scacioc A, Schalk AM, Krick R, Thumm M, Kühnel K.

Methods Mol Biol. 2016;1376:155-62. doi: 10.1007/978-1-4939-3170-5_13.

PMID:
26552682
15.

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries.

Panteli D, Eckhardt H, Nolting A, Busse R, Kulig M.

Health Res Policy Syst. 2015 Sep 25;13:39. doi: 10.1186/s12961-015-0028-5.

16.

Deciding when physicians are unfit to practise: an analysis of responsibilities, policy and practice in 11 European Union member states.

Struckmann V, Panteli D, Legido-Quigley H, Risso-Gill I, McKee M, Busse R.

Clin Med (Lond). 2015 Aug;15(4):319-24. doi: 10.7861/clinmedicine.15-4-319.

PMID:
26407378
17.

Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.

Röttger J, Blümel M, Engel S, Grenz-Farenholtz B, Fuchs S, Linder R, Verheyen F, Busse R.

Int J Health Policy Manag. 2015 May 20;4(7):431-7. doi: 10.15171/ijhpm.2015.97.

18.

[Erratum to: Teleradiological report turnaround times. An internal efficiency and quality control analysis].

Seithe T, Busse R, Rief M, Doyscher R, Albrecht L, Rathke H, Jonczyk M, Poschmann R, Tepe H, Hamm B, de Bucourt M.

Radiologe. 2015 Jun;55(6):497. doi: 10.1007/s00117-015-2864-2. German. No abstract available.

PMID:
26081675
19.

[Hemodiafiltration compared to hemodialysis regarding all-cause mortality and quality of life: a systematic review].

Panteli D, Wittenbecher F, Busse R.

Dtsch Med Wochenschr. 2015 May;140(11):e114-9. doi: 10.1055/s-0041-102110. Epub 2015 May 28. Review. German.

PMID:
26080729
20.

Characterization of PROPPIN-Phosphoinositide Binding and Role of Loop 6CD in PROPPIN-Membrane Binding.

Busse RA, Scacioc A, Krick R, Pérez-Lara Á, Thumm M, Kühnel K.

Biophys J. 2015 May 5;108(9):2223-34. doi: 10.1016/j.bpj.2015.03.045.

Items per page

Supplemental Content

Write to the Help Desk